LifeStance Health Group, Inc.
LFST
$6.45
-$0.08-1.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 382.20M | 363.81M | 345.31M | 332.97M | 325.48M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 382.20M | 363.81M | 345.31M | 332.97M | 325.48M |
| Cost of Revenue | 255.90M | 247.23M | 236.88M | 223.18M | 216.04M |
| Gross Profit | 126.30M | 116.58M | 108.43M | 109.79M | 109.44M |
| SG&A Expenses | 94.74M | 95.69M | 97.38M | 94.43M | 93.06M |
| Depreciation & Amortization | 13.43M | 13.56M | 14.01M | 13.76M | 14.67M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 364.08M | 356.48M | 348.26M | 331.37M | 323.77M |
| Operating Income | 18.12M | 7.33M | -2.95M | 1.60M | 1.71M |
| Income Before Tax | 15.20M | 4.57M | -5.94M | -1.47M | -8.88M |
| Income Tax Expenses | 3.54M | 3.50M | -2.15M | -2.18M | -1.76M |
| Earnings from Continuing Operations | 11.67M | 1.08M | -3.79M | 709.00K | -7.11M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.67M | 1.08M | -3.79M | 709.00K | -7.11M |
| EBIT | 18.12M | 7.33M | -2.95M | 1.60M | 1.71M |
| EBITDA | 31.55M | 20.89M | 11.06M | 15.36M | 16.38M |
| EPS Basic | 0.03 | 0.00 | -0.01 | 0.00 | -0.02 |
| Normalized Basic EPS | 0.02 | 0.01 | -0.01 | 0.00 | -0.01 |
| EPS Diluted | 0.03 | 0.00 | -0.01 | 0.00 | -0.02 |
| Normalized Diluted EPS | 0.02 | 0.01 | -0.01 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 387.00M | 386.96M | 386.73M | 383.27M | 380.45M |
| Average Diluted Shares Outstanding | 396.00M | 388.90M | 386.73M | 390.67M | 380.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |